Holds one valid CEP for ciprofibrate, filing since 2024. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 17 markets.
Holds one valid CEP for ciprofibrate, filing since 2023. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one valid CEP for ciprofibrate, filing since 2024.
Registered with DAV (Vietnam) for ciprofibrate. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for ciprofibrate. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for ciprofibrate.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for ciprofibrate and what filings they hold.
Chat with Fred, your AI analyst